Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 59Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Osteosarcoma 2Water Intoxication 1Psoriasis 1Ototoxicity 1Neoplasm, Residual 1Myasthenia Gravis 1Leukemia 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Dementia 1Central Nervous System Neoplasms 1Breast Neoplasms 1Breast Cancer Organoids 1Alzheimer Disease 1Acute Kidney Injury 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 60palbociclib 37Trastuzumab 31Letrozole 26Immunohistochemistry 26Drug Therapy 24Anastrozole 24Radiotherapy 21Gene Expression Profiling 20Amplified Fragment Length Polymorphism Analysis 20Mastectomy, Segmental 19Biopsy 19Tamoxifen 18exemestane 17Interviews as Topic 17ribociclib 16Mastectomy 16Fulvestrant 16Paclitaxel 15Magnetic Resonance Spectroscopy 15Psychiatric Rehabilitation 14High-Energy Shock Waves 14Polymerase Chain Reaction 13Observation 13Microarray Analysis 13Capecitabine 13trastuzumab deruxtecan 12Neoadjuvant Therapy 12Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Neoplasms × Methotrexate × Clear all
NCT06373744 2024-04-18

Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients

Sun Yat-sen University

Completed
597 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡